Depression is one of the most significant types of mental disorders and causes of disability worldwide. The World Health Organisation and the European Commission are constantly taking measures to ensure access to mental health services without unfair financial barriers and treatments based on both efficiency and economic equity.

The EU-funded Predictix project introduces Predictix ™, a user-friendly platform that analyses genomic, clinical and demographic data to generate a personalised report on the efficacy of antidepressants and their side effects. Through Predictix, medical practitioners will have up-to-date and accurate information on each case to improve and customise the care each patient receives.